Citadel Advisors’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.95M Sell
230,399
-3,869
-2% -$125K ﹤0.01% 3821
2025
Q4
$8.13M Buy
234,268
+192,070
+455% +$6.78M ﹤0.01% 3529
2025
Q3
$1.53M Sell
42,198
-162,019
-79% -$5.5M ﹤0.01% 6618
2025
Q2
$6.41M Buy
204,217
+150,581
+281% +$4.68M ﹤0.01% 3702
2025
Q1
$1.59M Sell
53,636
-22,034
-29% -$661K ﹤0.01% 5976
2024
Q4
$2.23M Buy
75,670
+16,562
+28% +$524K ﹤0.01% 5400
2024
Q3
$1.84M Sell
59,108
-169,844
-74% -$6.18M ﹤0.01% 5695
2024
Q2
$7.76M Buy
228,952
+166,927
+269% +$8.51M ﹤0.01% 3121
2024
Q1
$4.03M Sell
62,025
-178,331
-74% -$12.2M ﹤0.01% 4287
2023
Q4
$16.4M Buy
240,356
+68,784
+40% +$3.58M ﹤0.01% 2231
2023
Q3
$8.9M Buy
171,572
+135,695
+378% +$8.03M ﹤0.01% 2837
2023
Q2
$2.15M Sell
35,877
-24,445
-41% -$1.4M ﹤0.01% 5028
2023
Q1
$2.98M Sell
60,322
-139,266
-70% -$7.83M ﹤0.01% 4643
2022
Q4
$11.4M Sell
199,588
-94,814
-32% -$5.34M ﹤0.01% 2645
2022
Q3
$13.8M Buy
294,402
+209,902
+248% +$10M ﹤0.01% 2328
2022
Q2
$3.15M Buy
84,500
+24,774
+41% +$805K ﹤0.01% 4670
2022
Q1
$1.79M Buy
59,726
+47,603
+393% +$1.2M ﹤0.01% 6336
2021
Q4
$415K Sell
12,123
-10,405
-46% -$377K ﹤0.01% 10117
2021
Q3
$835K Sell
22,528
-28,782
-56% -$971K ﹤0.01% 8589
2021
Q2
$2M Sell
51,310
-126
-0.2% -$4.86K ﹤0.01% 6616
2021
Q1
$2.19M Buy
+51,436
New +$2.29M ﹤0.01% 6181

Other funds holding IMCR